Objective Despite availability of biologics and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit+13 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana+6 more
wiley +1 more source
Correction: Expression of glucocorticoid-receptor covaries with individual differences in visual lateralisation in zebrafish. [PDF]
Rovegno E+4 more
europepmc +1 more source
Characterization and Quantification of Epidermal and Dermal Glucocorticoid Receptors in the Rat
Kenneth T. Smith, Sam Shuster
openalex +1 more source
Evidence that the modulator of the glucocorticoid-receptor complex is the endogenous molybdate factor. [PDF]
Peter V.N. Bodine, Gerald Litwack
openalex +1 more source
The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease.
R. Oakley, J. Cidlowski
semanticscholar +1 more source
Expert Perspective: Hematologic Malignancies and Vasculitis
Arthritis &Rheumatology, EarlyView.
Michelle L. Robinette, Hetty E. Carraway
wiley +1 more source
Expert Perspective: Diagnosis and Treatment of Castleman Disease
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen+2 more
wiley +1 more source
The Role of the Glucocorticoid Receptor and Its Phosphorylation in Neurological Disorders. [PDF]
Gadwala S, Ghosh C.
europepmc +1 more source
Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone.
Judith E. Kalinyak+3 more
openalex +1 more source